Won-Tae Cha
Vermogen: 18 M $ op 31-08-2026
Vermogen: 18 M $ op 31-08-2026
Won-Tae Cha currently works at Cha Biotech Co., Ltd., as Chief Executive Officer from 2026, Cha Medical & Bio Group, as Vice Chairman, and Stem Cell & Regenerative Medicine International, Inc., as Director.
Mr. Cha received his undergraduate degree from Duke University, Masters Business Admin degree from Massachusetts Institute of Technology, graduate degree from Yale University, and doctorate degree from Yonsei University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 09-09-2026 | 3.110.518 ( 3,34% ) | 18 M $ | 31-08-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| CHABIOTECH CO.,LTD. | Algemeen Directeur | 04-03-2026 |
Stem Cell & Regenerative Medicine International, Inc.
Stem Cell & Regenerative Medicine International, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of human pluripotent stem cell technology in the field of regenerative medicine | Directeur/Bestuurslid | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 6 |
|---|---|
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yonsei University
Yonsei University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cha Biotech Co., Ltd.
Cha Biotech Co., Ltd. Electronic ComponentsElectronic Technology Manufactures and designs optical, digital, and medical products and related cell therapy and biological products | Electronic Technology |
Stem Cell & Regenerative Medicine International, Inc.
Stem Cell & Regenerative Medicine International, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of human pluripotent stem cell technology in the field of regenerative medicine | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau